Sonnet BioTherapeutics, Inc. (NASDAQ:SONN) | WebDisclosure

Basculer en Français

10370	Companies
216128	Keywords
145848	Articles
114444	Press releases

Headlines Articles Press releases Sonnet BioTherapeutics, Inc.

Home
Companies
Sonnet BioTherapeutics, Inc.

PRESS RELEASE

published on 02/29/2024 at 22:05, 2 years 2 months ago

Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
Sonnet BioTherapeutics Holdings, Inc. announced the publication of clinical data on SON-1010, a tumor-targeted immunotherapeutic drug combining FHAB construct with IL-12 in Frontiers in Immunology, showing favorable safety and tolerability

Clinical Data Sonnet BioTherapeutics SON-1010 Immunotherapeutic Drug FHAB Technology
PRESS RELEASE

published on 02/14/2024 at 13:30, 2 years 2 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
Sonnet BioTherapeutics Holdings, Inc. successfully raised $4.55 million, published preclinical data on SON-1210, executed NJ NOLs agreement, Phase 1b SON-080 trial enrollment completed, financial results announced for quarter ended Dec 31, 2023

Financial Results Preclinical Data Public Offering Sonnet BioTherapeutics Holdings NJ NOLs
PRESS RELEASE

published on 12/21/2023 at 14:00, 2 years 4 months ago

Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
PRESS RELEASE

published on 12/14/2023 at 22:15, 2 years 4 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
PRESS RELEASE

published on 10/31/2023 at 12:30, 2 years 6 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
PRESS RELEASE

published on 10/25/2023 at 13:30, 2 years 6 months ago

Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
PRESS RELEASE

published on 10/17/2023 at 14:00, 2 years 6 months ago

Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
PRESS RELEASE

published on 09/20/2023 at 13:30, 2 years 7 months ago

Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology

Accesswire

Published on 05/08/2026 at 15:55, 2 hours 32 minutes ago

Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 3 hours 27 minutes ago

Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 3 hours 32 minutes ago

Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 3 hours 57 minutes ago

Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 4 hours 27 minutes ago

BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program

View all ACCESSWIRE

EQS Group

Published on 05/08/2026 at 17:54, 32 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 05/08/2026 at 17:51, 36 minutes ago

Turkiye Garanti Bankasi A.S.: Board of Directors resolution regarding the foreign debt instrument issue limit
Published on 05/08/2026 at 17:00, 1 hour 26 minutes ago

Drägerwerk AG & Co. KGaA: Dräger’s annual shareholders’ meeting resolves on a significant dividend increase
Published on 05/08/2026 at 16:35, 1 hour 51 minutes ago

Edison issues report on Canadian General Investments (CGI)
Published on 05/08/2026 at 16:15, 2 hours 11 minutes ago

Inaugural Global Mediation Summit boosts Hong Kong’s status as a global mediation hub

Les Echos

Published on 05/07/2026 at 19:15, 23 hours 12 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 23 hours 12 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 23 hours 20 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 23 hours 20 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 23 hours 27 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE